ImmunologyJCI InsightPeer-reviewed
Pre-treatment naive T cells are associated with severe irAE following PD-1/CTLA4 checkpoint blockade for melanoma
Kathryne E. Marks, Alice Horisberger, Mehreen Elahee…·Deepak A. Rao
This study identifies pre-treatment naive CD4+ T cell abundance as a predictor of severe irAEs in patients receiving anti-PD-1/CTLA4 checkpoint inhibitor therapy for melanoma.
4 citations